Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes

George L. Bakris,Rajiv Agarwal,Stefan D. Anker,Bertram Pitt,Luis M. Ruilope,Peter Rossing,Peter Kolkhof,Christina Nowack,Patrick Schloemer,Amer Joseph,Gerasimos Filippatos

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes

2020

George L. Bakris
Rajiv Agarwal
Stefan D. Anker
Bertram Pitt
Luis M. Ruilope
Peter Rossing
Peter Kolkhof
Christina Nowack
Patrick Schloemer
Amer Joseph
Gerasimos Filippatos

Abstract Background Finerenone, a nonsteroidal, selective mineralocorticoid receptor antagonist, reduced albuminuria in short-term trials involving patients with chronic kidney disease (CKD) and ty...

Keywords:

Type 2 diabetes
Kidney disease
Medicine
Internal medicine
Finerenone

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

212

Citations